Cost and quality impacts of treatment loci for type 2 diabetes patients with moderate disease severity: Hospital- vs. GP-basedmonitoring

Ryan Wyeth Pullyblank (), Mauro Laudicella and Kim Rose Olsen ()
Additional contact information
Ryan Wyeth Pullyblank: University of Southern Denmark, DaCHE - Danish Centre for Health Economics, Postal: DaCHE - Danish Centre for Health Economics, Institut for Sundhedstjenesteforskning, Syddansk Universitet, J.B. Winsløws Vej 9B, 2. sal, DK-5000 Odense, Denmark
Kim Rose Olsen: University of Southern Denmark, DaCHE - Danish Centre for Health Economics, Postal: DaCHE - Danish Centre for Health Economics, Institut for Sundhedstjenesteforskning, Syddansk Universitet, J.B. Winsløws Vej 9B, 2. sal, DK-5000 Odense, Denmark

No 2020:1, DaCHE discussion papers from University of Southern Denmark, Dache - Danish Centre for Health Economics

Abstract: Objectives: This study investigates cost and quality implications of pushing regular monitoring of moderateseverity type 2 diabetes (T2D) patients away from specialized hospital clinics into general practice(GP). Methods: 152,630 hospital- and 21,361 GP-monitored T2D patients with moderate disease severity werealgorithmically identified in Danish administrative databases in 2016. Total annual healthcare costis decomposed into GP, medication, nonhospital-specialist, hospital outpatient and inpatient costs.Emergency hospitalizations are used to proxy for quality of care. Cost and quality impacts oftreatment loci are assessed using an instrumental variable (IV) analysis. A wide range of patientconfounders are used to reduce selection bias, with distance to nearest hospital diabetes clinic usedas an instrument to control for remaining endogeneity of treatment locus. Two-part models areused for zero-inflated outcomes. Results: Hospital monitoring is associated with higher total annual healthcare costs (64.0%, p Conclusion: For type 2 diabetes patients with moderate disease severity, IV analysis controlling for treatmentlocus endogeneity bias identifies an expected efficiency improvement (average cost reductionwithout reduction of quality) of moving regular disease management from hospital-based settingto primary care.

Keywords: Type 2 diabetes; Disease management; Cost; Quality of care; Administrative data (search for similar items in EconPapers)
JEL-codes: I18 (search for similar items in EconPapers)
Pages: 26 pages
Date: 2020-06-25
New Economics Papers: this item is included in nep-ore
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://findresearcher.sdu.dk:8443/ws/portalfiles/ ... ion_Paper_2020_1.pdf Full text (application/pdf)
Our link check indicates that this URL is bad, the error code is: 403 Forbidden

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hhs:sduhec:2020_001

DOI: 10.21996/f3x3-xz83

Access Statistics for this paper

More papers in DaCHE discussion papers from University of Southern Denmark, Dache - Danish Centre for Health Economics DaCHE - Danish Centre for Health Economics, Institut for Sundhedstjenesteforskning, Syddansk Universitet, J.B. Winsløws Vej 9B, 2. sal, DK-5000 Odense, Denmark. Contact information at EDIRC.
Bibliographic data for series maintained by Christian Volmar Skovsgaard ().